Open access · OA
via Europe PMC
GEROSCIENCE-DRIVEN THERAPIES TO TARGET HEALTHSPAN WITH AGING: CLINICAL IMPLICATIONS
Authors not listed
Innovation in aging · 2024
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Anonymous. (2024). GEROSCIENCE-DRIVEN THERAPIES TO TARGET HEALTHSPAN WITH AGING: CLINICAL IMPLICATIONS. <em>Innovation in aging</em>. https://europepmc.org/article/PMC/PMC11691230
Vancouver
Anonymous. GEROSCIENCE-DRIVEN THERAPIES TO TARGET HEALTHSPAN WITH AGING: CLINICAL IMPLICATIONS. Innovation in aging. 2024.
BibTeX
@article{anon2024GEROSC,
title = {GEROSCIENCE-DRIVEN THERAPIES TO TARGET HEALTHSPAN WITH AGING: CLINICAL IMPLICATIONS},
author = {Anonymous},
journal = {Innovation in aging},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Metabolism 2019
Open access · OA
Acceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes
HORMONES 2008
Open access · OA
Autophagy in aging and in neurodegenerative disorders
Advanced Drug Delivery Reviews 2008
Citation only
Clinical implications of mitochondrial disease
Journal of Dermatological Science 2009
Citation only
DNA damage responses in skin biology—Implications in tumor prevention and aging acceleration
NeuroMolecular Medicine 2014
Citation only
Epigenetic Regulation of Memory by Acetylation and Methylation of Chromatin: Implications in Neurological Disorders, Aging, and Addiction
Longevity & Healthspan 2014
Open access · OA